Catheter Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type (Cardiovascular Catheters( Electrophysiology Catheters, PTCA Balloon Catheters, IVUS Catheters, PTA Balloon Catheters), Urology Catheters (Hemodialysis Catheters, Peritoneal Catheters, Foley Catheters, Intermittent Catheters, External Catheters), Intravenous Catheters( Peripheral Catheters, Midline Peripheral Catheters, Central Venous Catheters), Neurovascular Catheters (Specialty Catheters, Wound/Surgical Catheters, Oximetry Catheters, Thermodilution Catheters, IUI Catheters), By End Use (Hospital Stores, Retail Stores, Others), By Region and Competition, 2021-2031F

Forecast Period	2027-2031
Market Size (2025)	USD 59.02 Billion
CAGR (2026-2031)	6.01%
Fastest Growing Segment	Hospital Stores
Largest Market	North America
Market Size (2031)	USD 83.77 Billion

Market Overview

The Global Catheter Market will grow from USD 59.02 Billion in 2025 to USD 83.77 Billion by 2031 at a 6.01% CAGR. A catheter is a thin medical tube inserted into a body cavity, vessel, or duct to allow the drainage, administration, or injection of fluids during surgical or therapeutic procedures. The primary drivers propelling the Global Catheter Market include the escalating prevalence of chronic conditions such as cardiovascular diseases and urinary disorders which necessitate minimally invasive interventions. Furthermore, the rapidly aging global population contributes to a higher volume of surgical operations requiring these devices for effective patient management. According to the American Heart Association, in 2024, cardiovascular disease accounted for approximately one out of every three deaths globally, indicating a substantial and sustained demand for cardiac interventional tools.

One significant challenge impeding market expansion is the high incidence of healthcare associated infections, particularly those related to urinary tract instrumentation. These complications often result in prolonged hospitalization and elevated medical costs, leading healthcare providers to implement rigorous protocols that may limit the routine or prolonged utilization of these devices.

Key Market Drivers

The surging adoption of minimally invasive diagnostic and surgical procedures is significantly propelling the global catheter market, as healthcare providers increasingly prioritize techniques that reduce patient trauma and recovery time. This shift has necessitated the development and high-volume consumption of specialized interventional tools, particularly in cardiac electrophysiology and structural heart therapies. The demand for these advanced catheter systems is evident in the financial performance of major industry players who are expanding their portfolios to meet clinical needs. According to Boston Scientific, October 2024, in the 'Q3 2024 Financial & Operational Highlights', the company’s Electrophysiology business, which utilizes the FARAPULSE Pulsed Field Ablation catheter system, reported a global net sales increase of 177.0% on a reported basis compared to the prior year period. Reflecting the broader industry momentum, according to Abbott, in 2024, the Medical Devices segment sales increased 11.7% on a reported basis to $4.75 billion in the third quarter, driven by double-digit growth in catheter-intensive areas such as electrophysiology and structural heart.

Simultaneously, the integration of smart sensors and AI-driven monitoring in catheter designs is redefining the market by enhancing clinical decision-making and patient safety. Manufacturers are moving beyond passive tubing to create intelligent systems capable of providing real-time hemodynamic data and predictive analytics, which is crucial for critical care settings. This trend is driving significant consolidation and capital allocation towards acquiring capabilities in advanced monitoring technologies. According to Becton, Dickinson and Company (BD), September 2024, in the press release 'BD Completes Acquisition of Edwards Lifesciences' Critical Care Product Group', the company finalized the strategic acquisition of Edwards' Critical Care unit for $4.2 billion in cash to expand its portfolio of smart connected care solutions and AI-enabled clinical decision tools. These strategic investments underscore the industry's pivot towards high-tech, sensor-integrated devices that offer superior value in complex medical environments.

Download Free Sample Report

Key Market Challenges

The widespread incidence of healthcare-associated infections (HAIs), particularly catheter-associated urinary tract infections (CAUTIs), acts as a substantial restraint on the Global Catheter Market. This challenge directly hampers market growth by forcing healthcare facilities to adopt rigorous "catheter-avoidance" strategies to minimize patient risk and control costs. Because hospitals often face financial penalties and non-reimbursement for hospital-acquired conditions, providers are increasingly implementing protocols that restrict the routine use of indwelling catheters or mandate their early removal. This operational shift significantly reduces the frequency of device utilization and the volume of replacement units required, thereby contracting the overall market demand for these consumables.

The continued prevalence of these infections reinforces the necessity for such restrictive measures, limiting the potential addressable market. According to the European Centre for Disease Prevention and Control, in 2024, urinary tract infections accounted for 19.2% of all healthcare-associated infections reported in acute care hospitals. This statistic highlights that despite advancements in care, urinary instrumentation remains a leading source of infectious complications. Consequently, the sustained focus on reducing this percentage compels healthcare systems to prioritize alternative management methods over catheterization, directly impeding the volume-driven growth of the market.

Key Market Trends

The expansion of home-based patient care is rapidly accelerating the adoption of hydrophilic single-use intermittent catheters. Users increasingly prefer these low-friction devices for self-catheterization because they reduce the risk of urethral trauma and complications associated with long-term indwelling tubes. This growing preference for independence and comfort is translating into higher volume sales for urology divisions focused on improved user experience. According to Coloplast, August 2024, in the 'Interim Financial Report, 9M 2023/24', the Continence Care business area reported an organic growth of 8% year-to-date, driven largely by the successful launch and uptake of the Luja intermittent catheter series.

Simultaneously, the development of next-generation balloon catheters utilizing intravascular lithotripsy is transforming the treatment of complex calcified cardiovascular lesions. These advanced devices use sonic pressure waves to fracture calcium within artery walls, offering a safer alternative to traditional high-pressure balloons that risk vessel dissection. Recognizing the high clinical value of this technology for treating coronary and peripheral artery disease, major conglomerates are heavily investing to secure these proprietary platforms. According to Johnson & Johnson, May 2024, in the press release 'Johnson & Johnson Completes Acquisition of Shockwave Medical', the company finalized the purchase of Shockwave Medical for an enterprise value of approximately $13.1 billion, specifically to extend its medtech leadership into heart recovery and vascular calcium modification.

Segmental Insights

The Hospital Stores segment is currently positioning itself as the fastest-growing distribution channel within the Global Catheter Market. This accelerated expansion is primarily driven by the global rise in hospital admission rates and the increasing volume of complex, minimally invasive surgical procedures that require immediate access to sterile, high-grade medical devices. Unlike retail alternatives, hospital stores are essential for managing the rigorous storage and handling protocols necessary for critical care and emergency settings. Furthermore, healthcare institutions are prioritizing centralized procurement through these internal stores to ensure strict adherence to safety compliance and to guarantee the timely availability of supplies for inpatient treatments.

Regional Insights

North America maintains the leading position in the global catheter market due to a well-established healthcare sector and the rising incidence of chronic ailments requiring interventional procedures. The region benefits significantly from the presence of major medical device manufacturers and high adoption rates of minimally invasive surgeries. Additionally, favorable reimbursement frameworks provided by the Centers for Medicare & Medicaid Services (CMS) facilitate patient access to essential medical products. This combination of strong industrial presence, regulatory support, and growing patient demand for effective treatments ensures North America remains the primary revenue generator in the global landscape.

Recent Developments

• In October 2024, Boston Scientific Corporation received approval from the U.S. Food and Drug Administration for the FARAWAVE Nav Ablation Catheter. This regulatory milestone allowed for the commercial launch of the navigation-enabled pulsed field ablation (PFA) catheter, which is utilized to treat paroxysmal atrial fibrillation. The device was engineered to function with the company's proprietary mapping software, providing visualization of catheter placement and shape during procedures. This launch expanded the company's electrophysiology portfolio, offering physicians an integrated system for cardiac mapping and ablation that utilizes non-thermal energy fields to treat abnormal heart rhythms.
• In October 2024, Medtronic plc obtained approval from the U.S. Food and Drug Administration for the Sphere-9 Catheter and the Affera Mapping and Ablation System. This all-in-one catheter was designed to deliver both pulsed field ablation and radiofrequency ablation, along with high-density mapping capabilities, through a single device. The system was approved for the treatment of persistent atrial fibrillation and enabled a workflow that eliminates the need for fluoroscopy. The company highlighted that this technology would improve procedural workflow by removing the requirement to exchange catheters during complex cardiac ablation procedures, thus optimizing resource utilization in electrophysiology labs.
• In September 2024, B. Braun Medical Inc. received 510(k) clearance from the U.S. Food and Drug Administration for the Introcan Safety 2 Deep Access IV Catheter. This device was designed to enable access to deeper veins in patients with difficult vascular access and to support longer dwell times. The catheter utilizes automatic passive safety needlestick protection and a multi-access blood control hub to minimize blood exposure. The company indicated that the longer-length catheter aimed to reduce the necessity for invasive alternatives like peripherally inserted central catheters (PICCs) and improve clinical efficiency by decreasing the frequency of procedure restarts.
• In April 2024, Johnson & Johnson entered into a definitive agreement to acquire Shockwave Medical for a total enterprise value of approximately $13.1 billion. Shockwave Medical developed an intravascular lithotripsy (IVL) technology, a catheter-based solution used to treat calcified arterial lesions in coronary and peripheral vessels. This acquisition expanded Johnson & Johnson’s position in the cardiovascular intervention market by adding a differentiated platform to its existing portfolio. The company noted that the integration of this technology would address unmet clinical needs and offer a minimally invasive alternative for managing complex calcified plaque, thereby enhancing treatment options for patients with cardiovascular disease.

Key Market Players

• Hollister Incorporated
• Medtronic PLC
• Boston Scientific Corporation
• Edward Lifesciences
• Smith Medical Inc.
• Teleflex Incorporated
• ConvaTec Group Plc
• Cure Medical LLC
• Terumo Corporation
• Cook Medical Inc.

By Product Type	By End Use	By Region
Cardiovascular Catheters( Electrophysiology Catheters, PTCA Balloon Catheters, IVUS Catheters, PTA Balloon Catheters) Urology Catheters (Hemodialysis Catheters, Peritoneal Catheters, Foley Catheters, Intermittent Catheters, External Catheters) Intravenous Catheters( Peripheral Catheters, Midline Peripheral Catheters, Central Venous Catheters) Neurovascular Catheters (Specialty Catheters, Wound/Surgical Catheters, Oximetry Catheters, Thermodilution Catheters, IUI Catheters)	Hospital Stores Retail Stores Others	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Catheter Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Catheter Market, By Product Type:

• Cardiovascular Catheters( Electrophysiology Catheters, PTCA Balloon Catheters, IVUS Catheters, PTA Balloon Catheters)
• Urology Catheters (Hemodialysis Catheters, Peritoneal Catheters, Foley Catheters, Intermittent Catheters, External Catheters)
• Intravenous Catheters( Peripheral Catheters, Midline Peripheral Catheters, Central Venous Catheters)
• Neurovascular Catheters (Specialty Catheters, Wound/Surgical Catheters, Oximetry Catheters, Thermodilution Catheters, IUI Catheters)

• Catheter Market, By End Use:

• Hospital Stores
• Retail Stores
• Others

• Catheter Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE